SUMMARY A single supervised oral dose of amoxycillin 3 g combined with clavulanic acid 125 mg as a suspension (Augmentin 3.125G) plus probenecid 1 g, cured 97 of 100 assessable patients who had uncomplicated anogenital gonorrhoea. Thirteen of the 100 patients were infected with penicillinase producing strains of Neisseria gonorrhoeae (PPNG) and 11 (85%o) of these patients were cured, including one infected with a PPNG strain that was also resistant to spectinomycin.
Introduction
The addition of clavulanic acid to amoxycillin is effective in restoring the antibacterial activity of amoxycillin against penicillinase producing strains of Neisseria gonorrhoeae (PPNG).1 PPNG strains have become more prevalent in many countries including Britain during the past few years, and parenteral drugs, such as spectinomycin or certain cephalesporins,2 have been recommended for treating gonorrhoea caused by these strains. Resistance to spectinomycin has, however, been recently recognised in some PPNG strains,34 and in many third world countries supervised oral rather than parenteral drug treatment is prefered as it is less expensive. [5] [6] [7] [8] We therefore decided to compare the efficacy of and tolerance to a single oral dose of Augmentin (amoxycillin 3 g combined with either 1 g with the current first line drug regimen used in this hospital, ampicillin 3 g plus probenecid 1 g, for treating uncomplicated gonorrhoea. 
